ATE146080T1 - Synergistische zusammensetzungen - Google Patents

Synergistische zusammensetzungen

Info

Publication number
ATE146080T1
ATE146080T1 AT91906872T AT91906872T ATE146080T1 AT E146080 T1 ATE146080 T1 AT E146080T1 AT 91906872 T AT91906872 T AT 91906872T AT 91906872 T AT91906872 T AT 91906872T AT E146080 T1 ATE146080 T1 AT E146080T1
Authority
AT
Austria
Prior art keywords
compositions
synergistic compositions
reductase
alpha
steroid
Prior art date
Application number
AT91906872T
Other languages
English (en)
Inventor
Michael Henry
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Application granted granted Critical
Publication of ATE146080T1 publication Critical patent/ATE146080T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Reproductive Health (AREA)
  • Dermatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Chemical And Physical Treatments For Wood And The Like (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT91906872T 1990-03-16 1991-03-13 Synergistische zusammensetzungen ATE146080T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB909006023A GB9006023D0 (en) 1990-03-16 1990-03-16 Synergistic compositions

Publications (1)

Publication Number Publication Date
ATE146080T1 true ATE146080T1 (de) 1996-12-15

Family

ID=10672772

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91906872T ATE146080T1 (de) 1990-03-16 1991-03-13 Synergistische zusammensetzungen

Country Status (8)

Country Link
EP (1) EP0521080B1 (de)
JP (1) JPH05506019A (de)
AT (1) ATE146080T1 (de)
AU (1) AU648551B2 (de)
CA (1) CA2076530A1 (de)
DE (1) DE69123573T2 (de)
GB (1) GB9006023D0 (de)
WO (1) WO1991013550A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SK137994A3 (en) * 1992-05-20 1995-04-12 Merck & Co Inc 7-beta-substituted-4-aza-5-alpha-cholestan-ons their using for production of pharmaceutical agent and pharmaceutical agent containing them
US5882681A (en) * 1993-09-03 1999-03-16 Smithkline Beecham Corporation Stabilized tablet formulation
IL111467A0 (en) * 1993-11-12 1994-12-29 Merck & Co Inc Pharmaceutical compositions comprising 7 beta -substituted -4-aza 5 alpha -cholestan-3-ones and 5 alpha reductase 1 inhibitors
GB9411103D0 (en) * 1994-06-03 1994-07-27 Smithkline Beecham Corp Compounds
US5543417A (en) * 1994-10-21 1996-08-06 Merck & Co., Inc. Combination method of treating acne using 4-AZA-5α-cholestan-ones and 4-AZA-5α-androstan-ones as selective 5α-reductase inhibitors with anti-bacterial, keratolytic, or anti-inflammatory agents

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4317817A (en) * 1979-08-27 1982-03-02 Richardson-Merrell Inc. Novel steroid 5α-reductase inhibitors
US4684635A (en) * 1984-05-11 1987-08-04 Norman Orentreich Compositions and methods for inhibiting the action of androgens

Also Published As

Publication number Publication date
JPH05506019A (ja) 1993-09-02
DE69123573D1 (de) 1997-01-23
CA2076530A1 (en) 1991-09-17
AU7573891A (en) 1991-10-10
DE69123573T2 (de) 1997-04-17
EP0521080B1 (de) 1996-12-11
EP0521080A4 (en) 1993-11-24
GB9006023D0 (en) 1990-05-09
WO1991013550A1 (en) 1991-09-19
HK1006542A1 (en) 1999-03-05
EP0521080A1 (de) 1993-01-07
AU648551B2 (en) 1994-04-28

Similar Documents

Publication Publication Date Title
ATE173880T1 (de) Biozide zusammensetzungen
MY103518A (en) Steroid 5- -reductase inhibitors
ES2124793T3 (es) Derivados de rapamicina alquilados en o y su uso, particularmente como inmunosupresores.
MX9204354A (es) Compuestos heterociclicos de 5 miembros, procedimiento para prepararlos y composiciones farmaceuticas que los contienen.
MX9203027A (es) Derivados heterociclicos de acilaminotiazoles y composicines farmaceuticas que los contienen.
PT951473E (pt) Novos derivados da ciclosporina sua preparacao e composicoes farmaceuticas que os contem
DK0705100T3 (da) Terapeutiske substituerede guanidiner
DK279790A (da) Aromatiske steroid-5-alfa-reduktaseinhibitorer
MX9300603A (es) Derivados tiaciclicos de piperidinilo.
MX9203099A (es) N-heterociclico-n-(4-piperidia)amidas y composiciones farmaceuticas y metodos que emplean dichos compuestos.
ATE212351T1 (de) Androsten-derivate
BG99177A (bg) Нови 7 бета-заместени-4-аза-5 алфа-холестанони като инхибитори на 5 алфа-редуктаза
ATE126666T1 (de) Imazalil enthaltende synergistische zusammensetzungen.
MX9704034A (es) Derivados y composiciones de 1,1-dioxido de 2-arilcarboniloximetil-1,2,5-tiadiazolidin-3-ona substituido y metodo de uso.
ATE146080T1 (de) Synergistische zusammensetzungen
ITRM920222A0 (it) Composizioni farmaceutiche conyenenti l-carnitina e acil- carnitine inassociazione con ace-inibitori per il trattamento di patologie cardiovascolari.
DE69432985D1 (de) Synergistische anthelmintische zusammensetzungen gegen fasciola hepatica und andere fascola spezien
NO20001758L (no) FremgangsmÕter og blandinger for behandling av leddgikt
FR2548900B1 (fr) Compositions pharmaceutiques synergiques
MX9203383A (es) Nuevos derivados de piridobenzoindol y composiciones farmaceuticas que los contienen.
IT8222911A0 (it) Derivati della 1-metil-5-nitro-imidazolina e composizioni terapeutiche che li comprendono come principio attivo.
MX9301939A (es) Composicion farmaceutica que comprende un compuesto inhibidor de 5-ó-reductasa esteroidal.
ES2054790T3 (es) Compuestos que tienen actividad cardiovascular.
MX9100886A (es) Activador de plasminogeno hibrido,procedimiento para su preparacion y composiciones farmaceuticas que lo contienen
TR22069A (tr) N-fosfonometilglisin ve bunun zirai bakimindan kabul edilebilir tuzlari ve sinerjistik hlbisidal terkipler